Specialty Pharmacy

FORT WORTH, Texas — Regional specialty pharmacy chain ReCept has appointed several people to new executive positions, the company said Wednesday.

ReCept, which owns 15 stores in Texas and specializes in compounding pharmacy services for people with such conditions as HIV/AIDS and cancer, announced the appointments of Nicky Otts as chairman and CEO, Carmine DeNardo as president and COO, Rob Jarvis as EVP sales and chief marketing officer, Jeff Brumbaugh as chief information officer and Stephanie Romero as VP finance.

ALTAMONTE SPRINGS, Fla. — Nearly all surveyed patients using BioPlus Specialty Pharmacy’s services over the last six years adhered to their therapies, according to recent statistics.

Quarterly data collected between 2004 and 2010 found that of 17,000 patients analyzed, compliance at the time of discharge was 92%.

ELMSFORD, N.Y. — Specialty pharmacy provider BioScrip has appointed David Froesel as EVP, CFO and treasurer, the company said Wednesday. Froesel will begin immediately, replacing Stan Rosembaum, who plans to leave the company before the year ends.

Froesel previously worked at Omnicare, which provides pharmaceutical care services to the elderly, for close to 14 years, serving as SVP and CFO from March 1996 until December 2009. Before working for Omnicare, Froesel worked at Mallinckrodt Group for 18 years.

NEW YORK — Leaders in specialty pharmacy gathered in New York on Tuesday at the New York Athletic Club to attend the second annual Specialty Pharmacy Roundtable discussion presented by Drug Store News and Armada Health Care.

David Galardi, co-founder of Apogenics Inc., moderated the robust panel, which was comprised of Nick Calla of Walgreens Specialty Pharmacy, John Musil of The Apothecary Shops, Tim Kaplan of Amber Pharmacy, Jeanne Ann Stasny of Walmart Specialty Pharmacy and Albert Thigpen of CVS Caremark, among others.

ROCKLAND, Mass. — The Food and Drug Administration has extended its review period for a multiple sclerosis drug made by EMD Serono, the drug maker said Friday.

EMD Serono — the U.S. subsidiary of German drug maker Merck KGaA, which uses the name to avoid confusion with U.S.-based Merck — said the FDA had extended the review time for cladribine tablets to Feb. 28. The drug is a disease-modifying drug for relapsing MS.

INDIANAPOLIS — Eli Lilly and Australian drug maker Acrux have received approval from the Food and Drug Administration for a testosterone replacement therapy for men, the two companies announced Tuesday.

The FDA approved Axiron (testosterone) topical solution as a treatment for men with various conditions that lead to deficiency of the hormone. The drug, a controlled substance, is designed for application under the arm.

NEW YORK A daily dose of an anti-retroviral pill appears to prevent HIV infection, according to results of a study conducted by University of California at San Francisco researchers, published in The New England Journal of Medicine on Tuesday.

LAKE MARY, Fla. Specialty pharmacy provider Axium Healthcare Pharmacy has received recognition from the National Hemophilia Foundation for its treatment programs, Axium said.

The NHF said Axium “meets or exceeds” the standards of the organization’s Medical and Scientific Advisory Council, meaning that it has staff knowledgeable about and provides a full range of treatments, has 24-hour access to pharmacy staff and has good record-keeping, billing and product recall processes.